CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AUTHORIZED GENERIC AGREEMENTAuthorized Generic Agreement • August 8th, 2024 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations • New York
THIS AUTHORIZED GENERIC AGREEMENT (this “Agreement”), is made effective as of April 26, 2024 (hereinafter the “Effective Date”), by and between:
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • August 8th, 2024 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations • Massachusetts
This Separation and Release Agreement (the “Agreement”) is made by and between Joseph Ciaffoni (the “Executive”) and Collegium Pharmaceutical, Inc. (the “Company”). The Executive together with the Company shall be referred to as the “Parties.”
LETTER AGREEMENTLetter Agreement • August 8th, 2024 • Collegium Pharmaceutical, Inc • Pharmaceutical preparations • Massachusetts
This Letter Agreement (this “Letter Agreement”) is entered into as of May 24, 2024, by and between Collegium Pharmaceutical, Inc. (the “Company”) and Michael Heffernan (“Chairman,” and together with the Company, the “Parties”).
